In keeping with previous studies, either PELI1 knockdown or Gefitinib treatment inhibited the ability of the migration, invasiveness and tumor spheres formation of MDA-MB-231 cells, which were further strongly enhanced by the combined treatments (Figs. 5A–C and S5A-C). This evidence concerns the gene PELI1 and neoplasm.